St. Jude Medical, Inc. (STJ) set a new milestone by introducing pacemaker devices in the U.S. with automatic test results and complete diagnostics facilities that can be accessed remotely via wireless communication. Yesterday, the company received the U.S. Food and Drug Administration (FDA) approval for these pacemakers - Accent RF and Anthem RF CRT.

In addition, St. Jude has received both the FDA and European CE Mark approval for the technology used in these pacemakers, version 4.0 of the Merlin.net Patient Care Network (PCN).

Accent and Anthem pacemakers use Radio Frequency (RF) telemetry that enables secure and smooth flow of data between the pacemaker and the clinician thereby enhancing the patient care. These devices use Merlin.net PCN technology that captures and records information about the performance of the pacemaker and the patient heart rhythm and subsequently send the data to a hospital’s Electronic Health Records system.

The new approval will add to